The risk factors for chemotherapy myelosuppression in breast cancer: a systematic review and meta-analysis
CIM is a common and significant adverse effect in breast cancer patients undergoing chemotherapy, influenced by multiple risk factors. Identifying and understanding these factors can provide a crucial theoretical basis for healthcare professionals to develop targeted strategies for prevention and management, ultimately enhancing patient outcomes.
Authors
- Ni Li (ORCID: https://orcid.org/0000-0001-5530-7745)
- Li Yang (ORCID: https://orcid.org/0000-0001-9016-1921)
- Duanna Zeng
- Yue Zhu (ORCID: https://orcid.org/0009-0002-2905-7855)
Institutions
- The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine (CN)
- Guangxi University of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Genetics
- Published
- 2025-12-08
- DOI
- https://doi.org/10.3389/fgene.2025.1704489
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00